Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,516 papers from all fields of science
Search
Sign In
Create Free Account
Paraplatin
Known as:
Paraplat
, Paraplatine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
49 relations
Broader (6)
Antineoplastic Agents
Carboplatin
Carcinogens
Cisplatin
Expand
BIC protocol
CAC protocol
CACE regimen
CEC protocol
Expand
Narrower (9)
CAC regimen
CAC6-300 protocol
CACAR protocol
CE regimen
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Polymer‐coated nanoparticles: Carrier platforms for hydrophobic water‐ and air‐sensitive metallo‐organic compounds
Daniel Valdepérez
,
Tianqiang Wang
,
+5 authors
B. Pelaz
Pharmacological Research
2017
Corpus ID: 37954739
2005
2005
Partial foot amputation in 11 dogs.
J. Liptak
,
W. Dernell
,
Scott A. Rizzo
,
S. Withrow
The Journal of the American Animal Hospital…
2005
Corpus ID: 13035059
Eleven dogs with malignant tumors of the digits and feet were treated with partial foot amputation. Partial foot amputation…
Expand
Review
2005
Review
2005
Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
M. Disis
Oncology
2005
Corpus ID: 20426508
Colony-stimulating factors are glycoproteins that act on hematopoietic cells by binding to specific cell surface receptors and…
Expand
Review
2004
Review
2004
Carboplatin in combination therapy for metastatic breast cancer.
E. Perez
The Oncologist
2004
Corpus ID: 8469322
BACKGROUND Anthracycline-based regimens have a limited role in patients with metastatic breast cancer due to cumulative…
Expand
Review
2003
Review
2003
Erlotinib: preclinical investigations.
M. Hidalgo
Oncology
2003
Corpus ID: 38479854
Erlotinib (Tarceva) is an orally available selective small-molecule inhibitor of HER1/EGFR tyrosine kinase with a 50% inhibitory…
Expand
Review
2002
Review
2002
Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer.
M. Edelman
Lung Cancer
2002
Corpus ID: 8822511
1999
1999
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft
S. Weitman
,
G. Mangold
,
+5 authors
D. V. Von Hoff
Cancer Chemotherapy and Pharmacology
1999
Corpus ID: 30106059
Purpose: Tirapazamine (3-amino-1,2,4-benzotriazine 1,4-dioxide; SR 4233) is a bioreductive agent that exhibits relatively…
Expand
1996
1996
Evoked-potential thresholds and cubic distortion product otoacoustic emissions in the chinchilla following carboplatin treatment and noise exposure
Brenda M. Jock
,
R. Hamernik
,
L. Aldrich
,
W. Ahroon
,
Kristen-Lyn Petriello
,
A. R. Johnson
Hearing Research
1996
Corpus ID: 4706762
Highly Cited
1996
Highly Cited
1996
Ring-Opened Adducts of the Anticancer Drug Carboplatin with Sulfur Amino Acids.
K. Barnham
,
M. Djuran
,
P. D. S. Murdoch
,
J. Ranford
,
P. Sadler
Inorganic Chemistry
1996
Corpus ID: 24097770
Reactions of the anticancer drug carboplatin ("Paraplatin") with a variety of sulfur-containing amino acids have been…
Expand
1988
1988
Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
E. Douple
,
M. D. Totten
,
F. Spencer
NCI monographs : a publication of the National…
1988
Corpus ID: 21810477
To design protocols for exploitation of the potential for interaction among the platinum (Pt) chemotherapeutic agents cisplatin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE